Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Deutsche Bank analyst David Hoang initiated coverage on Kymera Therapeutics Inc (NASDAQ:KYMR) with a Hold rating and announced a price target of $120. Kymera Therapeutics shares closed at $105.25 on Wednesday. See how other analysts view this stock.
  • UBS analyst Nicolas Gaudois initiated coverage on SK Hynix Inc – ADR (NASDAQ:SKHY) with a Buy rating and announced a price target of $204. SK Hynix closed at $126.79 on Wednesday. See how other analysts view this stock.
  • Rodman & Renshaw analyst Michael G. King Jr. initiated coverage on Actuate Therapeutics Inc (NASDAQ:ACTU) with a Buy rating and announced a price target of $6. Actuate Therapeutics shares closed at $1.08 on Wednesday. See how other analysts view this stock.

Considering buying SKHY stock? Here’s what analysts think:

Photo via Shutterstock